AllerPops

AllerPops

Early Stage

Liberate millions from allergies

Liberate millions from allergies

Overview

Raised to Date: Raised: $253,517

Total Commitments ($USD)

Platform

Wefunder

Start Date

02/22/2021

Close Date

04/30/2021

Min. Goal
$50,000
Max. Goal
$500,001
Min. Investment

$100

Security Type

Equity - Preferred

Series

Series A

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$0.89

Pre-Money Valuation

$7,500,000

Rolling Commitments ($USD)

Status
Funded
Reporting Date

05/01/2021

Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise

$3,841

# of Investors

295

Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2016

Industry

Healthcare & Pharmaceuticals

Tech Sector

Medtech

Distribution Model

B2C

Margin

High

Capital Intensity

High

Location

Los Alamos, New Mexico

Business Type

Growth

AllerPops, with a pre-money valuation of $7.5 million, is raising funds on Wefunder. The company makes prebiotic lollipops that help people fight against allergies the natural way. The lollipops are all-natural, drug-free, and made with FDA-approved food ingredients. Cliff Han founded AllerPops in 2016. The proceeds of the current crowdfunding round, with a minimum target of $50,000 and a maximum target of $500,001, will be used for marketing, clinical trial, inventory and product development, and international patent application. AllerPops already has three patents issued from USPTO and has filed five international patent applications. The lollipops have helped over 5,000 customers with an efficacy rate of 94.5% and have already generated over $120,000 in revenue.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$58,360

$20,549

COGS

$8,327

$4,035

Tax

$0

$0

 

 

Net Income

$-136,665

$-163,330

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$64,089

$4,916

Accounts Receivable

$150

$0

Total Assets

$204,095

$84,579

Short-Term Debt

$17,342

$4,496

Long-Term Debt

$199,131

$0

Total Liabilities

$216,473

$4,496

Financials as of: 02/22/2021
Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
AllerPops 07/30/2023 Wefunder $9,769,000 $461,047 Equity - Common Funded RegCF
AllerPops 04/29/2021 Wefunder $7,500,000 $253,517 Equity - Preferred Funded RegCF
Create a free account today to gain access to KingsCrowd analytics.

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Valuation History

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Employee History

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
AllerPops on Wefunder
Platform: Wefunder
Security Type: Equity - Preferred
Valuation: $7,500,000
Price per Share: $0.89

Follow company

Follow AllerPops on Wefunder

Buy AllerPops's Deal Report

Warning: according to the close date for this deal, AllerPops may no longer be accepting investments.

AllerPops Deal Report

Get KingsCrowd’s comprehensive report on AllerPops including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether AllerPops is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the AllerPops deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge